Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00128154
Status:
COMPLETED
Last Update Posted:
2006-08-18
First Post:
2005-08-05
Brief Title:
Chromium Picolinate for the Treatment of Metabolic Syndrome
Sponsor:
National Center for Complementary and Integrative Health NCCIH
Organization:
National Center for Complementary and Integrative Health NCCIH
Study Overview
Official Title:
A Double-Blind Randomized Controlled Clinical Trial of Chromium Picolinate on Clinical and Biochemical Features of the Metabolic Syndrome
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether chromium supplements can reduce symptoms of metabolic syndrome a collection of symptoms that increase ones risk for developing heart disease stroke and diabetes
Detailed Description:
Metabolic syndrome is a serious condition that may lead to a number of life-threatening diseases A reduction in the symptoms of metabolic syndrome could result in decreased morbidity and health care costs and increased quality of life
Chromium is an essential mineral that is used in the breakdown of fats protein and carbohydrates The cholesterol-lowering and blood sugar-stabilizing properties of chromium make the supplement a strong candidate for reducing the symptoms of metabolic syndrome This study will determine whether chromium supplements can reduce symptoms of metabolic syndrome in abdominally obese individuals
Participants will be randomly assigned to receive either chromium supplements or placebo daily for 16 weeks Participants will have study visits at study start and at Months 2 and 4 A follow-up visit will occur 5 months after the end of the intervention period Blood tests urine tests and nail clippings will be used to assess lipoprotein cholesterol insulin response to glucose lean body mass blood pressure oxidative stress and chromium levels in participants
Chromium is an essential mineral that is used in the breakdown of fats protein and carbohydrates The cholesterol-lowering and blood sugar-stabilizing properties of chromium make the supplement a strong candidate for reducing the symptoms of metabolic syndrome This study will determine whether chromium supplements can reduce symptoms of metabolic syndrome in abdominally obese individuals
Participants will be randomly assigned to receive either chromium supplements or placebo daily for 16 weeks Participants will have study visits at study start and at Months 2 and 4 A follow-up visit will occur 5 months after the end of the intervention period Blood tests urine tests and nail clippings will be used to assess lipoprotein cholesterol insulin response to glucose lean body mass blood pressure oxidative stress and chromium levels in participants
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None